June 29, 2022 at 3:46 pm

MISSD’s Latest Public Health Video is Reaching More than 350 People Every Day

MISSD is pleased our latest public health video has had more than 44,500 views since its release. That’s an average of 350 people per day who are learning that prescription drug-induced akathisia is a suicide risk factor. Please see and share https://www.youtube.com/c/MISSDFoundation/videos

June 24, 2022 at 2:22 pm

MISSD’s Akathisia Videos Can Reduce Suffering and Save Lives

MISSD’s public health videos have had more than 665K views. Please share them to help ensure others are well informed about akathisia and related adverse drug effects. See https://www.youtube.com/watch?v=ER4JGnRssSk.

June 17, 2022 at 2:46 pm

Elderly SSRI Consumers and the Increased Risk of Serotonin Toxicity

A new study finds older adults taking SSRIs are at an increased risk of serotonin syndrome. It’s also important to note that people suffering from serotonin toxicity can also be suffering from SSRI-induced akathisia. Read the full article at https://www.madinamerica.com/2022/06/antidepressant-induced-serotonin-syndrome-danger-elderly/

June 8, 2022 at 7:12 am

Akathisia is a Suicide Risk Factor Everyone Should Know

MISSD’s latest video is the first suicide prevention video to include akathisia as a suicide risk factor. Please see and share. https://www.youtube.com/watch?v=2r9lcvh90kE

May 26, 2022 at 10:56 am

Adverse Drug Effects and Mental Health Awareness Month

“During Mental Health Awareness Month, we hear suicide prevention and mental health organizations promoting pharmaceutical products as treatments while staying silent about adverse drug effects that can harm our mental wellbeing,” said Wendy Dolin, MISSD founder.

See more at https://www.einpresswire.com/article/573938198/fda-black-box-label-warns-of-suicide-risks?r=pawvHNLdeLOjws8eSt

May 20, 2022 at 6:53 am

NHS Stats Reflect 41% Increase in Prescribing Antidepressants to Children ages 5-12

The Pharmaceutical Journal reports that NHS data shows there’s been a 41% increase in the number of children aged 5–12 years who were prescribed antidepressants in the last six years. Yet withdrawal problems including akathisia are seldom discussed prior to prescription.

Kristen Shukla, a child psychiatrist at Oxford Health NHS, states, “The difficulties with withdrawing from these drugs has only more recently been acknowledged. There is a very high risk that children who start taking these drugs when very young will continue taking them for many years and into adulthood.” Read the full article at https://www.madinamerica.com/2022/05/nhs-data-41-rise-antidepressant-prescribing-children-aged-5-12-since-2015/

May 10, 2022 at 1:30 pm

Tune in to our Latest Akathisia Stories Podcast

Geraldine and Cindy discuss her late father’s prescribed harm. Louis was given drugs marketed as antidepressants and later prescribed Seroquel off-label. He soon grew increasingly anxious and developed classic symptoms of akathisia that were not accurately diagnosed and treated. He paced, rocked back and forth, and remarked on his new and worsening symptoms. Louis eventually ended his akathisia suffering by ending his life. Listen and learn at https://www.studiocchicago.com/akathisia-stories

May 6, 2022 at 7:41 am

As DSM Diagnosis Expands, More People are Prescribed Psychiatric Drugs–and Often Not Warned of Serious Side Effects

The overprescribing of psychiatric drugs is a growing health problem that puts people at risk of permanent harm. One out of six Americans are now prescribed psych drugs, often without warning of drug dependency and critical risks to include akathisia.

Read the full article at https://www.theepochtimes.com/the-problematic-overprescription-of-psychiatric-drugs_4429336.html

April 25, 2022 at 2:54 pm

Antidepressants Don’t Appear To Improve Long-Term Quality of Life, Finds New Study

A new study finds that antidepressant drugs may not improve long-term quality of life. “If we don’t expect improvement from the continuous use of these medications, then the correct decision might be to stop the continuous use of these medications,” said Omar Almohammed, a pharmacologist at King Saud University in Saudi Arabia and a co-author of the study.

Read the full article at https://www.nytimes.com/2022/04/21/well/antidepressants-ssri-effectiveness.html

April 19, 2022 at 10:37 am

We’re Minding the Gap in Akathisia Awareness & Medical Training

“Passengers on the Tube are routinely informed to “Mind the Gap” at each stop to help ensure a safe journey,” said MISSD founder Wendy Dolin. “Similarly, our train adverts spotlight a major healthcare gap so that patients can be better informed and safer. Most patients have never heard of akathisia, and some prescribers are unaware of the causes, symptoms, and potentially fatal risks.”

Read more about MISSD’s London Underground Awareness Campaign at https://www.einpresswire.com/article/568379273/new-adverts-on-the-london-underground-are-increasing-akathisia-awareness-to-reduce-suicide